‘Dual-warhead’ a key differentiator for ADCs, says Synaffix
Antibody-drug conjugate (ADC) technology developer Synaffix has been granted a US patent for its dual-warhead HydraSpace platform.
Archives for May 16, 2017
A happy medium for stem cells? Irvine Scientific launches GMP xeno-free offering
Xeno-free and cGMP-manufactured media are highly desired by cell therapy developers, says Irvine Scientific as it launches a medium for hematopoietic stem and progenitor cells (HSPCs).
Thermo Fisher: $7.2bn Patheon sits in sweet spot for bioproduction business
Thermo Fisher says Patheon will become the most competitive biologics CDMO in the market through direct access to its bioprocessing technologies and capabalities.